OphthoAcademy logo OphthoAcademy
OphthoAcademy logo OphthoAcademy
Ocular Trauma · Triage & Blunt Trauma

Traumatic Hyphema

On this page
  1. What a Hyphema Is
  2. Grading
  3. Initial Management and Admission Criteria
  4. Rebleeding Risk
  5. Complications
  6. Sickle Cell Disease and Trait
  7. High-Yield Pearls
  8. Related Topics

What a Hyphema Is

A traumatic hyphema is free blood layering within the anterior chamber following blunt (or, less commonly, penetrating) ocular trauma. The most common source of bleeding is tearing of vessels of the major arterial circle at the iris root or anterior ciliary body — the same structures torn in iridodialysis and angle recession, since blunt trauma compresses and rebounds the globe hard enough to shear all of them. Because gravity pulls the red cells down, blood classically layers inferiorly in the anterior chamber, giving the fluid level that's visible on slit lamp or even penlight exam.

Grading

Hyphemas are described using a standard four-tier grading system based on how much of the anterior chamber is filled with blood:

Higher grades correlate with a higher risk of both acutely elevated IOP and downstream complications, which is why grade is one of the key inputs into the admission decision below.

Initial Management and Admission Criteria

Standard initial management centers on limiting rebleeding and catching pressure spikes early: bed rest, head elevation, a protective eye shield, cycloplegia and topical steroids as indicated, and close monitoring of intraocular pressure. Antiplatelet and anticoagulant medications — aspirin included — should be avoided wherever possible, since they increase the risk of the rebleed described below. Vigorous ocular massage and early surgical washout for low-grade hyphemas are not part of standard care.

Not every hyphema needs admission — a reliable adult with good follow-up access and an isolated, low-grade hyphema with normal pressure can often be managed as an outpatient. What most strongly favors inpatient admission instead is sickle cell trait or disease combined with elevated intraocular pressure: that combination raises the risk of optic nerve damage significantly and needs closer, more aggressive inpatient monitoring than a routine hyphema does. See the sickle cell section below for why.

Rebleeding Risk

The period of greatest risk for a secondary hemorrhage (rebleed) is generally cited as roughly two to five days after the initial injury — as the traumatic clot begins to retract and undergoes fibrinolysis, the vessel it was sealing can reopen. A rebleed is not a minor event: it carries a higher risk of complications than the original hemorrhage, including a greater chance of significant IOP elevation and corneal blood staining. This is the clinical reasoning behind continued activity restriction and avoidance of antiplatelet agents in the days following injury, not just at the moment of presentation.

Complications

The late complication of a large hyphema most likely to cause permanent corneal damage is corneal blood staining. Persistently elevated intraocular pressure drives red blood cells into the corneal stroma, where they break down and deposit hemoglobin breakdown products that can permanently impair vision if the staining is extensive or long-standing. This is a direct consequence of prolonged high IOP in the setting of a large hyphema, which is another reason aggressive pressure control is central to management — it isn't just about comfort, it's about protecting the cornea. Secondary (angle recession) glaucoma is a separate, delayed complication that can follow the same traumatic event — see the anterior segment signs page for how that develops over months to years.

Sickle Cell Disease and Trait

Sickle cell status changes hyphema management meaningfully, and it's one of the highest-yield associations in ocular trauma. In the relatively hypoxic, acidotic aqueous humor environment of an eye with a hyphema, red blood cells carrying hemoglobin S sickle more readily. Sickled cells are stiffer and less deformable than normal red cells, so they obstruct the trabecular meshwork more effectively — meaning a patient with sickle cell trait or disease can develop optic nerve damage from a level of IOP elevation that other patients would tolerate without injury. This is why elevated IOP in a sickle cell patient with hyphema is treated more aggressively and monitored more closely, and why sickle cell status should be checked (or already known) in essentially every hyphema patient of African, Mediterranean, Middle Eastern, or South Asian ancestry.

Common Pitfall — Carbonic Anhydrase Inhibitors and Sickle Cell

Carbonic anhydrase inhibitors (CAIs) such as acetazolamide are a standard part of the IOP-lowering toolkit in ordinary hyphema management — but they should generally be avoided in patients with sickle cell disease or trait. Systemic CAIs promote acidosis and hemoconcentration, which can worsen red cell sickling and further obstruct trabecular outflow — the opposite of the intended effect. Reaching for a CAI reflexively in a sickle cell patient with hyphema can make the underlying problem worse rather than better; alternative IOP-lowering strategies are preferred instead.

High-Yield Pearls

High-Yield
  • Grade I <1/3 fill, Grade IV = total ("eight-ball") hyphema with dark clotted blood — grade tracks with IOP-spike and staining risk.
  • Rebleeding risk peaks roughly days 2–5 post-injury, as the initial clot retracts and lyses — this is when activity restriction matters most.
  • Corneal blood staining is driven by sustained high IOP, not by the hyphema itself — pressure control is what prevents it.
  • Sickle cell trait/disease + elevated IOP is a strong admission criterion, and it's a reason to avoid systemic CAIs specifically.
  • Most common bleeding source: the major arterial circle at the iris root/anterior ciliary body — the same vessels torn in iridodialysis.

Continue exploring Ocular Trauma:

Ocular Trauma Triage & Initial Assessment Blunt Trauma — Anterior Segment Signs Blunt Trauma — Posterior Segment Signs

Test yourself on Traumatic Hyphema

OphthoAcademy has real practice questions on this exact subtopic, with spaced repetition to help it stick.

Try it in your browser